Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine vs Standard Induction and Decitabine Maintenance in Older AML
NCT02085408Phase 3Completed
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Feb 2011
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 3 trial of clofarabine, decitabine in acute myeloid leukemia (AML), sponsored by ECOG-ACRIN Cancer Research Group. Started Feb 2011; status: completed.
02
Drugs
clofarabinedecitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02085408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02085408.